The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Buscopan Rx 10mg Coated Tablets

10 milligram(s) Coated tablet

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/190/001

Main Information

Trade NameBuscopan Rx 10mg Coated Tablets
Active SubstancesHyoscine butylbromide
Strength10 milligram(s)
Dosage FormCoated tablet
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/190/001

Group Information

ATC CodeA03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
A03BB01 butylscopolamine


Licence Issued02/12/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back